Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (3 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (2)
Type
(
1 selected
)
Type
Guidance (781)
Guidance programme
(
2 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (224)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (27)
Interventional procedures guidance (598)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (340)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (754)
Apply filters
Showing 601 to 610 of 781
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Highly specialised technologies guidance
Remove Guidance programme: Highly specialised technologies guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Naloxegol for treating opioid‑induced constipation
TA345
22 July 2015
22 July 2015
Aflibercept for treating diabetic macular oedema
TA346
22 July 2015
22 July 2015
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer
TA347
22 July 2015
22 July 2015
Everolimus for preventing organ rejection in liver transplantation
TA348
22 July 2015
22 July 2015
Secukinumab for treating moderate to severe plaque psoriasis
TA350
22 July 2015
22 July 2015
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal)
TA351
22 July 2015
22 July 2015
Omalizumab for previously treated chronic spontaneous urticaria
TA339
8 June 2015
8 June 2015
Vedolizumab for treating moderately to severely active ulcerative colitis
TA342
5 June 2015
5 June 2015
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism
TA341
4 June 2015
4 June 2015
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia
TA343
2 June 2015
2 June 2015
Previous page
1
…
59
60
Current page
61
62
63
…
79
Page
61
of
79
Next page
Results per page
10
25
50
All
Back to top